Soleno Therapeutics
Tracked across 8 events · 571 articles · First seen Jan 29, 2026 · Last active Apr 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Soleno Therapeutics is facing multiple investigations for possible violations of federal securities laws after a report by Scorpion Capital alleged problems with its drug DCCR, leading to significant stock price declines and concerns within the Prader-Willi syndrome community. The company also disclosed a patient death after taking DCCR, further impacting its stock and launch trajectory.
Mar 10, 2026 · 7 articles
Regulatory
Soleno Therapeutics is facing a securities fraud class action lawsuit for alleged misrepresentations concerning its Phase 3 clinical trial program for DCCR, which could negatively impact its stock price and reputation.
Mar 12, 2026 · 7 articles
Regulatory
Soleno Therapeutics is facing a class action lawsuit for allegedly misrepresenting safety concerns related to its drug DCCR, leading to significant stock price declines and reputational damage. The lawsuit claims the company downplayed risks of excess fluid retention and a patient death after taking DCCR.
Mar 07, 2026 · 7 articles
Regulatory
Soleno Therapeutics is facing a class action lawsuit for allegedly making false and misleading statements regarding the safety and commercial viability of its drug DCCR. This could lead to significant financial penalties and reputational damage.
Mar 09, 2026 · 180 articles
Regulatory
Soleno Therapeutics is facing a class action lawsuit for allegedly making false and misleading statements regarding the safety and commercial viability of its DCCR treatment. This could lead to significant financial penalties and reputational damage for the company.
Mar 09, 2026 · 7 articles
+ 3 more events
View on Dashboard
100
Soleno Therapeutics allegedly made false and misleading statementsSoleno Therapeutics Faces...
90
Soleno Therapeutics made false and/or misleading statementsSoleno Therapeutics Faces...
90
Rosen Law Firm initiated class action lawsuit Soleno TherapeuticsSoleno Therapeutics Faces...
90
Rosen Law Firm filed class action lawsuit Soleno TherapeuticsSoleno Therapeutics Faces...
85
Kahn Swick & Foti notified investors of class action lawsuit Soleno TherapeuticsSoleno Therapeutics Faces...
80
Monteverde & Associates PC launched investigation into proposed transactions Soleno TherapeuticsMonteverde & Associates PC...
NEWSDESK
Track Soleno Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard